Skip to search formSkip to main contentSkip to account menu

salivary plasminogen activator alpha 1, Desmodus rotundus

Known as: DESMOTEPLASE, Plasminogen Activator (Desmodus rotundus Isoform Alpha-1 Protein Moiety Reduced), DSPA alpha 1 protein, Desmodus rotundus 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Background and Purpose— Numerous contraindications included in the license of alteplase, most of which are not based on… 
Highly Cited
2009
Highly Cited
2009
BackgroundThe common vampire bat Desmodus rotundus is an excellent model organism for studying ecological vicariance in the… 
Highly Cited
2008
Highly Cited
2008
Background and Purpose— The Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) unadjusted results… 
Review
2008
Review
2008
Today there exists only one FDA-approved treatment for ischemic stroke; i.e., the serine protease tissue-type plasminogen… 
Highly Cited
2003
Highly Cited
2003
Background and Purpose— Tissue-type plasminogen activator (tPA) promotes excitotoxic and ischemic injury within the brain. These… 
Review
1999
Review
1999
Between 1989 and 1995, twenty caves in the Distrito Federal area in mid-western Brazil were assessed for bat species richness… 
Highly Cited
1997
Highly Cited
1997
In Erwinia amylovora, the dsp region, required for pathogenicity on the host plant but not for hypersensitive elicitation on…